Anhong capital acquires majority equity of Shanxi Guangsheng pharmaceutical packaging Co., Ltd


On December 15, the interface news learned that the private equity investment fund Anhong capital announced today, It has completed the acquisition of Shanxi Guangsheng pharmaceutical packaging Co., Ltd. (hereinafter referred to as “Guangsheng capsule”), the largest capsule manufacturer in China, from Meihua Biotechnology Group Co., Ltd. and its co investors )Majority ownership. Guangsheng capsule produces gelatin capsule, enteric coated capsule, cellulose capsule and pullulan polysaccharide capsule. The products are sold to pharmaceutical and health product enterprises all over China and exported to North America, Europe, Southeast Asia and other countries and regions.
Anhong capital focuses on business and financial services, health care, industry, retail, consumer goods and leisure, as well as technology, media and telecommunications. As of June 30, 2021, the company’s asset management scale has reached US $81 billion.